Triastek

Triastek

Private
JiangsuHealthcare & Life Scienceshttps://www.triastek.com

Last Round

VC Round

Sep 28, 2023

Total Funding Raised

$65M

Company Overview

Triastek is a pharmaceutical technology company specializing in innovative 3D printing solutions for the development and production of drug delivery systems.

Sector

Healthcare & Life Sciences

Verticals

3D Printing, Biotechnology, Smart Manufacturing, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

3D printed pharmaceuticalsdrug delivery technologymelt extrusion depositionMED3D printed drugscontrolled-release drugspharmaceutical 3D printingdrug formulationoral solid dosage formsprogrammed drug releasegastric retention drugspharmaceutical co-development3D printed pillscontinuous manufacturingcolon-targeted deliveryGMP manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Triastek Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Triastek Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 28, 2023
Series B ExtensionNov 23, 2021
Series BJun 24, 2021
Series ADec 15, 2020

Key People

Founding team and executive leadership

Senping Cheng

CEO

Executive Team

Triastek Investors

Notable investors and investment history

InvestorRounds
MatrixSeries B Extension, Series B
CPE (CPE Yuanfeng)Series B
Goldmine Multi-family OfficeVC Round
Tasly Holding GroupSeries B
Dalton VentureSeries B, Series A
Triwise CapitalSeries B Extension
Morningside VenturesSeries B

Triastek Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Triastek Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Triastek's valuation, stock price, and market status.

Firmographic Details

HeadquartersJiangsu
Employee Range31
Year Founded2015
Last FundingSep 28, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.